Evidence map›Paper›PMID 31240167›Full record

ArticleJIMD reports2019

Survey of quality of life, phenotypic expression, and response to treatment in Krabbe leukodystrophy.

Thomas J Langan, Amy Barczykowski, Kabir Jalal, Laura Sherwood, Heather Allewelt, Joanne Kurtzberg, Randy L Carter

Open access · goldAbstract read
In one paragraph

Article in JIMD reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Thomas J LanganDepartment of Neurology, School of Medicine and Biomedical Sciences University at Buffalo Buffalo New York.
Amy BarczykowskiDepartment of Biostatistics, Population Health Observatory, School of Public Health and Health Professions University at Buffalo Buffalo New York.
Kabir JalalDepartment of Biostatistics, Population Health Observatory, School of Public Health and Health Professions University at Buffalo Buffalo New York.
Laura SherwoodDepartment of Neurology, School of Medicine and Biomedical Sciences University at Buffalo Buffalo New York.
Heather AlleweltDepartment of Pediatrics Duke University School of Medicine Durham North Carolina.
Joanne KurtzbergDepartment of Pediatrics Duke University School of Medicine Durham North Carolina.
Randy L CarterDepartment of Biostatistics, Population Health Observatory, School of Public Health and Health Professions University at Buffalo Buffalo New York.
University at Buffalo, State University of New York · USDuke University · US

Funding

Training & EducationU54NS065768 · NINDS · UNIVERSITY OF MINNESOTA · PI WHITLEY, CHESTER B. · 2009 to 2024
$17.7M
Enhancement Newborn Screening to Improve the Efficacy of Cord Blood Transplant for Krabbe DiseaseR21HD087818 · NICHD · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI CARTER, RANDOLPH LEE, LANGAN, THOMAS J · 2016 to 2017
$439k
NICHD NIH HHS R21 HD087818NINDS NIH HHS U54 NS065768
6 · The paper itself

Abstract

objectivesTo develop a quality of life (QOL) survey for Krabbe disease (KD), and to thereby improve understanding of its phenotypic expression and response to treatment.

methodsThe survey, the Leukodystrophy Quality of Life Assessment (LQLA) and the Vineland Adaptive Behavior Scales were co-administered to 33 patients or their caretakers. These included the phenotypes of early infantile KD (EIKD; 0-6 months old at onset), late infantile cases (LIKD; 7-12 months old at onset), and cases that emerged after 12 months old, late onset (LOKD). The sample included cases with and without stem cell transplantation (SCT). Reliability and concurrent validity were assessed for overall and subscale scores. Analysis of variance tested differences in QOL between phenotypes and transplant groups (none, pre-, post-symptom).

resultsGood concurrent validity with the Vineland was shown for total, communication, daily activity, social, and motor scales and good reliability was observed. LOKD cases had better communication skills than either EIKD or LIKD and better overall QOL than EIKD. Analyses of individual items showed that communication items, mostly, contributed significantly to phenotype differences. Presymptomatic SCT significantly improved QOL compared to postsymptomatic SCT or no treatment. Presymptomatically treated patients had near-normal total scores.

conclusionsThe LQLA is valid and reliable. Despite small sample size, phenotypic demarcation was determined to be due mainly to differences in communication skills. There was a relative enhancement of QOL in LOKD patients, and in those who had presymptomatic SCT. These results apply to the current controversy about recommendations for newborn screening for this condition.

Indexed as

neurodegenerationnewborn screeningtransplantation

Identifiers

PMID31240167
PMCPMC6498827
OpenAlexW2943849915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.